Multiple analyses in clinical trials: sound science or data dredging?
- 18 October 2004
- journal article
- review article
- Published by AMPCo in The Medical Journal of Australia
- Vol. 181 (8) , 452-454
- https://doi.org/10.5694/j.1326-5377.2004.tb06376.x
Abstract
Click on the article title to read more.This publication has 17 references indexed in Scilit:
- Empirical Evidence for Selective Reporting of Outcomes in Randomized TrialsJAMA, 2004
- Subgroup analysis: application to individual patient decisionsThe Medical Journal of Australia, 2004
- One-Year Clinical Results With the Slow-Release, Polymer-Based, Paclitaxel-Eluting TAXUS StentCirculation, 2004
- Subgroup analysis in clinical trialsThe Medical Journal of Australia, 2004
- Secondary Prevention of Cardiovascular Events With Long-Term Pravastatin in Patients With Diabetes or Impaired Fasting GlucoseDiabetes Care, 2003
- Phase III Trial of Doxorubicin, Paclitaxel, and the Combination of Doxorubicin and Paclitaxel as Front-Line Chemotherapy for Metastatic Breast Cancer: An Intergroup Trial (E1193)Journal of Clinical Oncology, 2003
- Randomisation in clinical trialsThe Medical Journal of Australia, 2002
- The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trialsThe Lancet, 2001
- Clinical trials with multiple outcomes: A statistical perspective on their design, analysis, and interpretationControlled Clinical Trials, 1997
- Some Thoughts on Clinical Trials, Especially Problems of MultiplicityScience, 1977